Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(ENZ, BOB.V, AVNW, KEYP, ARIA) CRWEFinance.com Stocks in Action

|Includes: ARIAD Pharmaceuticals, Inc. (ARIA), AVNW

crwefinancelogo2

chartstockalert

http://pennyomega.com/img/enz.jpg ENZ, Enzo Biochem, Inc.

ENZ is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.

The business activities of ENZ are performed by the company's three wholly owned subsidiaries . . . Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. Such activities include research and development, manufacturing and marketing of biomedical research products and tools through Enzo Life Sciences and research and development of therapeutic products through Enzo Therapeutics and the operation of a regional clinical reference laboratory through Enzo Clinical Labs.

ENZ recently reported improved sequential results for the first fiscal quarter ended October 31, 2010

ENZ Generated Positive EBITDA, Improving $2.9 Million Sequentially.

More about ENZ at www.enzo.com

*****************************************

 

 

http://pennyomega.com/img/bob.jpg Global Hunter Corp. (TSX.V:BOB) (FSE:G5D)

BOB.V's focus is on strategic and base metals, particularly copper and molybdenum

BOB.V's flagship project is the La Corona de Cobre property, located 70 kilometres north of La Serena, Chile, along the Pan American Highway, within the coastal belt of the Andean Cordillera. The NI 43-101-compliant resource contains 225 million pounds of copper oxide. In addition, the Company has its Rabbit South molybdenum project in south-central British Columbia, Canada.

There may be insufficient reserves to sustain current high rates of copper consumption. Some countries, such as Chile and the United States, still have sizeable reserves of the metal which are extracted through large open pit mines.

BOB.V recently completed a surface sampling program at La Corona de Cobre. The program was designed to collect surface samples from the numerous prospective shear zones. This will aid in the definition of drill targets to expand on the copper oxide mineralization.

More about BOB.V at www.globalhunter.ca

*****************************************

Aviat Networks, Inc. (Nasdaq:AVNW) recently reported that John J. Madigan will succeed J. Russell Mincey as Vice President, Corporate Controller and Principal Accounting Officer. Mr. Mincey will be leaving Aviat Networks as a result of the closing of the company's North Carolina offices and the move of its corporate headquarters to Santa Clara, California. Mr. Mincey will remain employed with the company as an advisor through March 4, 2011, to help with the transition of his function.

Aviat Networks, Inc. engages in the design, manufacture, and sale of a range of wireless networking products, solutions, and services worldwide.

*****************************************

Keyuan Petrochemicals, Inc. (Nasdaq:KEYP) recently reported a plan to expand its design production capacity by approximately 30% from 550,000 to 720,000 metric tons (NYSE:MT) per year.

Keyuan Petrochemicals, Inc. operating through its subsidiary manufactures and distributes petrochemical products in China.

*****************************************

Ariad Pharmaceuticals Inc. (Nasdaq:ARIA) recently reported updated clinical data from a fully enrolled and ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with resistant and refractory chronic myeloid leukemia (NYSE:CML) and Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). The study demonstrates that in chronic-phase CML patients treated with ponatinib, 66 percent of patients in the trial achieved a major cytogenetic response, including 100 percent of patients who also had a T315I mutation.

ARIAD Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer in the United States, Europe, and Japan.

********************************************************************

http://crwefinance.com/img/crwefinance_new_buscard2.jpg

Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from Global Hunter Corp. (TSX Venture Exchange (TSX.V:BOB) and the Frankfurt Stock Exchange (FSE:G5D)) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company.